LRP6 and breast carcinoma: Furthermore, we observed a significant decrease in cytosolic β-catenin after gigantol treatment (Fig. 4a-b), indicating that gigantol inhibits Wnt/β-catenin signaling in breast cancer cells by suppressing LRP6 expression.